http://www.codesria.org/?q=1&p...onolactone http://www.codesria.org/?q=1&p...mg-picture 100mg clomid symptoms http://www.codesria.org/?q=1&p...e-in-delhi what are the chances of twins on clomid 150 mg
tadalafil generico italia 
http://www.capitalvision.fr/ma...n-c-arique 
http://www.capitalvision.fr/ma...a-pas-cher 
comparatif viagra 
rezeptfrei viagra bestellen 
viagra levitra farmaci generici viagras en pharmacie kamagra oral jelly 100mg comprar cialis generico cialis farmacias guadalajara http://yoolab.wustl.edu/?comps...0-mg-venta precio de cialis 20 mg en farmacias farmacias que venden viagra sin receta en madrid cialis 5mg forum cialis generique 10mg
    venlafaxine er 75 mg hot flashes http://he.manhigut.org/?itemid...iews-forum proscar price canada finasteride tablets price in india bupropion xl 150 mg high

Prevalence and Treatment Management of Oropharyngeal Candidiasis in Cancer Patients: Results of the French Candidoscope Study

Tue, Sep 20, 2011

Oral Cancer News

Source: RedJournal.org

Purpose

The aim of this pharmaco-epidemiological study was to evaluate the prevalence of oropharyngeal candidiasis (OPC) in cancer patients treated with chemotherapy and/or radiotherapy.

Methods and Materials

Signs and symptoms of OPC were noted for all patients. Antifungal therapeutic management was recorded in OPC patients. Patients receiving local antifungal treatments were monitored until the end of treatment.

Results

Enrolled in the study were 2,042 patients with solid tumor and/or lymphoma treated with chemotherapy and/or another systemic cancer treatment and/or radiotherapy. The overall prevalence of OPC was 9.6% (95% confidence interval, 8.4%–11.0%] in this population. It was most frequent in patients treated with combined chemoradiotherapy (22.0%) or with more than two cytotoxic agents (16.9%). Local antifungal treatments were prescribed in 75.0% of OPC patients as recommended by guidelines. The compliance to treatment was higher in patients receiving once-daily miconazole mucoadhesive buccal tablet (MBT; 88.2%) than in those treated with several daily mouthwashes of amphotericin B (40%) or nystatin (18.8%).

Conclusion

OPC prevalence in treated cancer patients was high. Local treatments were usually prescribed as per guidelines. Compliance to local treatments was better with once-daily drugs.

This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

Print Friendly
Be Sociable, Share!
, , , , ,

Leave a Reply

You must be logged in to post a comment.